21 studies found for:    "Stargardt disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Stargardt disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Conditions: Stargardt Disease;   Stargardt Macular Degeneration;   Stargardt Macular Dystrophy;   Autosomal Recessive Stargardt Disease 1 (ABCA4-related)
Interventions: Drug: ALK-001;   Drug: Placebo
2 Unknown  Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease
Condition: Stargardt Disease
Intervention:
3 Active, not recruiting A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
Condition: Stargardt Disease
Intervention:
4 Recruiting Phase I/IIa Study of SAR422459 in Patients With Stargardt's Macular Degeneration
Condition: Stargardt Disease
Intervention: Drug: SAR422459
5 Active, not recruiting The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
Condition: Stargardt Disease
Intervention:
6 Enrolling by invitation A Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration
Condition: Stargardt Disease
Intervention: Drug: SAR422459
7 Completed Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: MA09-hRPE
8 Active, not recruiting Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: MA09-hRPE
9 Completed Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: MA09-hRPE
10 Unknown  Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)
Condition: Stargardt's Macular Dystrophy
Intervention: Biological: MA09-hRPE
11 Recruiting Rod and Cone Mediated Function in Retinal Disease
Conditions: Retinal Degeneration;   Retinitis Pigmentosa;   Stargardt's Disease
Intervention:
12 Active, not recruiting DHA Supplementation in Patients With STGD3
Condition: Dominantly Inherited Stargardt's Disease (STGD3)
Intervention: Dietary Supplement: Over the counter DHA/EPA dietary supplementation
13 Recruiting Inherited Retinal Degenerative Disease Registry
Conditions: Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
Intervention:
14 Completed Phase 1 Safety Study of ALK-001 in Healthy Volunteers
Conditions: Stargardt Disease;   Age-related Macular Degeneration;   Other Retinal Dystrophies
Intervention: Drug: ALK-001 (No generic name)
15 Completed Microcurrent Stimulation to Treat Macular Degeneration
Conditions: Retinal Diseases;   Stargardt's Disease;   Retinitis Pigmentosa
Intervention:
16 Completed Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
Condition: Macular Degeneration
Intervention: Drug: Docosahexaenoic Acid (DHA) Dietary Supplement
17 Recruiting Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
Conditions: Macular Degeneration;   Stargardt's Macular Dystrophy
Intervention: Procedure: Subretinal transplantation
18 Completed Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
Condition: Macular Dystrophy, Corneal
Interventions: Drug: 4-Methylpyrazole;   Other: saline
19 Active, not recruiting Saffron Supplementation in Stargardt's Disease
Conditions: Retinal Degeneration;   Genetic Disease;   Single-Gene Defects;   Macular Dystrophy
Interventions: Dietary Supplement: Saffron supplementation;   Other: placebo
20 Recruiting Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
Conditions: Genotype;   Retinal Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Indicates status has not been verified in more than two years